What You Should Know:

您应该知道：

–       OncoveryCare (formerly VivorCare) has closed an oversubscribed $4.5 million seed financing to launch its novel cancer survivorship care model.

–OncoveryCare（前身为VivorCare）已经完成了450万美元的超额认购种子融资，以推出其新型癌症幸存者护理模式。

–       The fundraise was led by .406 Ventures alongside the McKay Institute for Oncology Transformation at Tennessee Oncology. Tennessee Oncology, which treats half of Tennessee’s cancer patients at 35 sites, is also a founding member of OneOncology, a fast-growth oncology platform dedicated to supporting independent oncology practices through capital, technology and expertise. .

–此次募资由0.406家企业和田纳西州肿瘤学的麦凯肿瘤学转化研究所共同领导。田纳西肿瘤学在35个地点治疗田纳西州一半的癌症患者，也是OneOncology的创始成员，OneOncology是一个快速增长的肿瘤学平台，致力于通过资本、技术和专业知识支持独立的肿瘤学实践。。

OncoveryCare Secures Seed Financing and Partners with Tennessee Oncology to Revolutionize Cancer Survivorship Care

OncoveryCare获得种子资金，并与田纳西州肿瘤学合作，彻底改变癌症幸存者护理

OncoveryCare is making strides in cancer survivorship care with its latest Seed financing round, led by .406 Ventures and supported by Oncology Ventures and Techstars. Concurrently, OncoveryCare announced a strategic partnership with Tennessee Oncology, enabling the company to extend its care model to patients throughout Tennessee..

OncoveryCare通过其最新一轮种子融资，在癌症幸存者护理方面取得了长足进步，该轮融资由0.406家风险投资公司牵头，并得到了肿瘤学风险投资公司和Techstars的支持。与此同时，OncoveryCare宣布与田纳西州肿瘤学建立战略合作伙伴关系，使该公司能够将其护理模式扩展到整个田纳西州的患者。。

The population of cancer survivors in the US is projected to double from 11 million in 2008 to 22 million by 2030, driven by the rising incidence of cancer and improved survival rates due to advancements in treatment. Cancer survivors face significant post-treatment needs, including management of cardiotoxicity, cancer-related fatigue, complex screening and monitoring protocols, as well as mental health challenges such as anxiety and depression related to their diagnosis and treatment.

受癌症发病率上升和治疗进步带来的生存率提高的推动，预计美国癌症幸存者人数将从2008年的1100万增加到2030年的2200万。癌症幸存者面临着巨大的治疗后需求，包括心脏毒性管理，癌症相关疲劳，复杂的筛查和监测方案，以及与诊断和治疗相关的焦虑和抑郁等心理健康挑战。

Despite these needs, survivorship care is often fragmented and unstructured, relying heavily on an overburdened oncology workforce, which results in high costs and suboptimal outcomes. OncoveryCare aims to address this gap in the cancer care continuum..

尽管有这些需求，幸存者护理往往是零散和无组织的，严重依赖于负担过重的肿瘤学工作人员，这导致高成本和次优结果。OncoveryCare旨在解决癌症护理连续性中的这一差距。。

Launching with a virtual care model, OncoveryCare provides a comprehensive support system for cancer survivors through a team of clinicians specialized in survivorship. The initial focus areas include toxicity management, mental health support, navigation and care planning, and preventative care. To facilitate the deployment of this model, OncoveryCare has partnered with the McKay Institute, the innovation arm of Tennessee Oncology, one of the nation’s largest community-based cancer care providers.

OncoveryCare以虚拟护理模式启动，通过一个专门从事幸存者工作的临床医生团队，为癌症幸存者提供全面的支持系统。最初的重点领域包括毒性管理，心理健康支持，导航和护理计划以及预防保健。为了促进这种模式的部署，OncoveryCare与麦凯研究所（McKay Institute）合作，麦凯研究所是田纳西州肿瘤学的创新部门，田纳西州肿瘤学是美国最大的社区癌症护理提供者之一。

This partnership will help scale the intervention across Tennessee Oncology’s survivor population with the broader aim of extending it to the wider oncology community..

这种伙伴关系将有助于扩大田纳西州肿瘤学幸存者的干预范围，并将其扩展到更广泛的肿瘤学社区。。

The Seed financing will empower OncoveryCare to expand its care delivery model and develop new tools and approaches to broaden access to high-quality survivorship care. By offering comprehensive, whole-person care, OncoveryCare supports the rapidly growing population of cancer survivors, ensuring they receive the personalized, longitudinal care needed to lead healthier and happier lives..

种子基金将授权OncoveryCare扩大其护理服务模式，并开发新的工具和方法，以扩大获得高质量生存护理的机会。OncoveryCare通过提供全面的全人护理，为快速增长的癌症幸存者提供支持，确保他们获得个性化的纵向护理，从而过上更健康、更幸福的生活。。

“Survivorship is the next frontier in cancer care delivery,” explained Hil Moss, Co-founder and Chief Executive Officer of OncoveryCare, whose own experience as a breast cancer survivor motivated her to launch the company. “For decades we have been focused on finding the cure for cancer. Now we have to answer the question: what happens when people survive?” .

OncoveryCare联合创始人兼首席执行官希尔·莫斯（HilMoss）解释道：“幸存者是癌症护理服务的下一个前沿领域”，她自己作为乳腺癌幸存者的经历促使她创办了这家公司。“几十年来，我们一直致力于寻找治疗癌症的方法。现在我们必须回答这个问题：当人们存活下来时会发生什么？”。